A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention
2015 · New England Journal of Medicine · 610 citations
https://doi.org/10.1056/nejmoa1506197
H
Haryana M. Dhillon
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
375
Papers
9.9K
Citations
48
h-index
164
i10-index
Haryana M. Dhillon is an academic researcher from University of Sydney. The author has contributed to research in topics: Cancer survivorship and care & Cancer-related cognitive impairment studies & Palliative Care and End-of-Life Issues. The author has an h-index of 48, co-authored 319 publications.
ORCID: 0000-0003-4039-5169Papers by this author
worksStructured Exercise after Adjuvant Chemotherapy for Colon Cancer
2025 · New England Journal of Medicine · 134 citations
https://doi.org/10.1056/nejmoa2502760
Comparison of two standard chemotherapy regimens for good-prognosis germ-cell tumours: a randomised trial
2001 · The Lancet · 125 citations
https://doi.org/10.1016/s0140-6736(00)04165-9
Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
2009 · British Journal of Cancer · 103 citations
https://doi.org/10.1038/sj.bjc.6605239
Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients
2023 · New England Journal of Medicine · 91 citations
https://doi.org/10.1056/nejmoa2203086
What are the optimal measures to identify anxiety and depression in people diagnosed with head and neck cancer (HNC): a systematic review
2020 · Journal of Patient-Reported Outcomes · 34 citations
https://doi.org/10.1186/s41687-020-00189-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat